What's breaking now, across thousands of outlets.
Bambusa Therapeutics Inc. shares slipped 7% in its trading debut after the early-stage biotech focused on dermatology and autoimmune diseases raised $168.9 million in a US initial public offering.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
The chipmaker is falling despite a competitor's bullish results.
Pakistani human rights lawyer Imaan Mazari and her husband Hadi Ali Chattha have been sentenced to 10 years in prison in a case involving the removal of road barriers during an England cricket team's…
AstraZeneca’s leadership hinted at where the cost cuts and job losses from the company’s new restructuring program might fall on a call with journalists Friday.
Data indicate cheap cars are selling fast, but a few lower-priced segments still saw sales drop in the third quarter. Here's what might be happening.
Is Intel's guidance miss really bad news for Cerebras?
Zenith Bank Group reported pre-tax profit of N928.80 billion for the nine months ended September 2026, up 1.24% from N917.41 billion in the corresponding period of 2025.
